These observations were re-confirmed by confocal microscopy of endogenous SOX2 protein that once again documented a disappearance of SOX2 signal upon AKT inhibition, and a restoration of SOX2 protein in BC cells co-treated with MK-2206 and bortezomib (Figure 7E). The gene discussed is AKT1; the disease is breast cancer.